This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Meridian Bioscience Inc (VIVO)

NASDAQ: Health Care

$19.11
04/29/16 - 4:00:00 PM ET
  • Prev Close: 19.85
  • Avg Vol: 250.30K
  • Shares Outstanding: 42.05M
  • Mkt Cap: 834.72M
  • Div: $0.20
  • Div Yield: 4.00%
  • P/E: 22.82
  • EPS: 0.80
VIVO Day's Range
$19.02
$19.97
VIVO 52 Week Range
$16.60
$21.49
Trade Now:
VIVO Business Summary
Meridian Bioscience, Inc., a life science company, develops, manufactures, and distributes diagnostic test kits primarily for various gastrointestinal, viral, respiratory, and parasitic infectious diseases worldwide. The company operates through Diagnostics and Life Science segments.View VIVO key stats
Meridian Bioscience Inc - VIVO - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Meridian Bioscience Inc as a Buy with a ratings score of A-.
Report Snippet: We rate MERIDIAN BIOSCIENCE INC (VIVO) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, solid stock price performance, expanding profit margins and notable return on equity. We feel its strengths outweigh the fact that the company has had sub par growth in net income.
Rating: 4.33 out of 5, 'A-' Buy.
You can view the full analysis from the report here:
VIVO Rating Report
VIVO Performance as of Prev. Close
YTD
-6.82%
3-Mo
-0.68%
1-Yr
2.85%
3-Yr
-4.21%
VIVO EPS Performance
1-Yr Ago
0.80
2-Yrs Ago
0.80
3-Yrs Ago
0.90
VIVO Percentage in these ETFs
0.160%
0.040%
0.015%
0.013%
0.006%
VIVO News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

VIVO Meridian Bioscience Inc

Chart of VIVO

Analysts Ratings for VIVO

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 1 1
Moderate Buy 0 0 1 1
Hold 3 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 2 2 2 2
GET VIVO ANALYST REPORT

VIVO Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs